Application of 9-demethylberberine in preparation of hypolipidemic drug

A technology for desmethylberberine and medicine is applied in the application field of 9-desmethylberberine in the preparation of blood lipid-lowering medicines, and can solve the problems of rhabdomyolysis, pharmacokinetic influence, reduction of medicine effect and the like

Inactive Publication Date: 2014-07-16
CHINA PHARM UNIV
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Clinically, although statins and other drugs have good lipid-lowering effects, long-term use may cause toxic side effects such as liver toxicity and rhabdomyolysis, and have a greater impact on drug-metabolizing enzymes in the liver
However, changes in the expression and activity of drug-metabolizing enzymes in the liver may affect the pharmacokinetics of co-administered drugs in vivo, resulting in drug interactions and resulting in reduced drug efficacy or toxic side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 9-demethylberberine in preparation of hypolipidemic drug
  • Application of 9-demethylberberine in preparation of hypolipidemic drug
  • Application of 9-demethylberberine in preparation of hypolipidemic drug

Examples

Experimental program
Comparison scheme
Effect test

example 9

[0009] Example 9-Demethylberberine lipid-lowering effect

[0010] C57BL / 6 mice (30, purchased from the Academy of Military Medical Sciences, weighing 18±2g) were used for the experiment. With AIN93 standard feed (according to calorific value, containing 10% fat, 75.9% carbohydrate, 14.1% protein, 3601 kcal / kg) and standard feeding environment (free eating and drinking, alternate day and night, each 12 hours), adapt Sex feeding for a week. Subsequently, they were randomly divided into 5 groups by body weight, one group continued to be given normal feed, and the other four groups were all given high-fat feed (calculated by calorie value, containing 60% fat, 25.9% carbohydrate, 14.1% protein, and 5018 kcal of heat). / kg) (Nantong Trofe Feed Technology Co., Ltd.), and all rats had free access to drinking water. The above-mentioned 5 groups of animals were fed under the same conditions. Blood was collected at 3 weeks, serum plasma was separated, and total triglyceride (TG), total...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a hypolipidemic compound 9-demethylberberine. The 9-demethylberberine is derived from a main in-vivo metabolite of natural medicine berberine, and is also named as berberrubine. The researches on model animals with hyperlipidemia find that the 9-demethylberberine has good drug effects of reducing cholesterol, triglyceride, low density lipoprotein (LDL) and the like, and has no obvious side effects for 6 weeks of continuous medication. The discovery can lead to discovery of a new hypolipidemic drug, and provides another alternative medicine for clinic treatment of hyperlipidemia, lipid metabolism disorder and high fat and obese patients and related people wanting to lose weight.

Description

technical field [0001] The present invention relates to 9-desmethyl berberine with lipid-lowering pharmacological effects and its potential clinical application, in particular to 9-desmethyl berberine showing good lipid-lowering effect on hyperlipidemia model animals, which is expected to pass Further research and development will become a class of innovative drugs, which are used for clinically lowering blood lipids, regulating abnormal lipid metabolism and used for weight loss of obese people. Background technique [0002] Hyperlipidemia is a major risk factor for cardiovascular and cerebrovascular diseases and an important factor that endangers human health. Clinically, although statins and other drugs have good lipid-lowering effects, long-term use may cause toxic side effects such as liver toxicity and rhabdomyolysis, and have a greater impact on drug-metabolizing enzymes in the liver. The changes in the expression and activity of drug-metabolizing enzymes in the liver...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4375A61P3/06A61P3/04A61P3/10A61P3/00
Inventor 阿基业王广基孙润彬葛纯杨娜俞晓忆肖文璟
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap